Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 3, 2013, Pages 2419-2430

  Bai, Rui ^a   Liu, Wanlin ^a   Zhao, Aiqing ^b   Zhao, Zhenqun ^a   Jiang, Dianming ^c  

^a The Second Hospital of Inner Mongolia Medical University   (China)

^b The Affiliated Hospital of Inner Mongolia Medical University   (China)

^c THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; MTHFR; Polymorphism; Vertebral fractures

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; CONFIDENCE INTERVAL; FRACTURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HIP FRACTURE; HOMOZYGOTE; HUMAN; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SPINE FRACTURE; SYSTEMATIC REVIEW;

ALLELES; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; FRACTURES, BONE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIP FRACTURES; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK; SPINAL INJURIES;

EID: 84878378050     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2322-4     Document Type: Article

References (49)

1. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276-1287
2. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
3. Ensrud KE, Schousboe JT (2011) Clinical practice. Vertebral fractures. N Engl J Med 364:1634-1642
4. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929-1936
5. Stewart TL, Ralston SH (2000) Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 166:235-245
6. Hosoi T (2010) Genetic aspects of osteoporosis. J Bone Miner Metab 28:601-607
7. Cheung CL, Xiao SM, Kung AW (2010) Genetic epidemiology of age-related osteoporosis and its clinical applications. Nat Rev Rheumatol 6:507-517
8. Goyette P, Pai A, Milos R et al (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9:652-656
9. Kang SS, Zhou J, Wong P et al (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414
10. Goyette P, Sumner JS, Milos R et al (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200
11. Weisberg I, Tran P, Christensen B et al (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172
12. Villadsen MM, Bunger MH, Carstens M et al (2005) Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int 16:411-416
13. Urano W, Furuya T, Inoue E et al (2009) Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients. J Bone Miner Metab 27:574-583
14. Zhu K, Beilby J, Dick IM et al (2009) The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int 20:1183-1191
15. Bathum L, von Bornemann Hjelmborg J, Christiansen L et al (2004) Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased risk of fractures: results from a population-based Danish twin study. Osteoporos Int 15:659-664
16. Yazdanpanah N, Uitterlinden AG, Zillikens MC et al (2008) Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele. J Bone Miner Res 23:86-94
17. Gjesdal CG, Vollset SE, Ueland PM et al (2007) Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study. J Bone Miner Res 22:747-756
18. Abrahamsen B, Madsen JS, Tofteng CL et al (2003) A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 18:723-729
19. Shiraki M, Urano T, Kuroda T et al (2008) The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures. J Bone Miner Metab 26:595-602
20. Valero C, Alonso MA, Zarrabeitia MT et al (2007) MTHFR C677T polymorphism and osteoporotic fractures. Horm Metab Res 39:543-547
21. Jorgensen HL, Madsen JS, Madsen B et al (2002) Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women. Calcif Tissue Int 71:386-392
22. Agueda L, Urreizti R, Bustamante M et al (2010) Analysis of three functional polymorphisms in relation to osteoporosis phenotypes: replication in a Spanish cohort. Calcif Tissue Int 87:14-24
23. Li M, Lau EM, Woo J (2004) Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women. Bone 35:1369-1374
24. Hong X, Hsu YH, Terwedow H et al (2007) Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone 40:737-742
25. Attia J, Thakkinstian A, D'Este C (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56:297-303
26. Petitti DB (2000) Meta-analysis, decision analysis, and cost effectiveness analysis: methods for quantitative synthesis in medicine, vol 2. Oxford University Press, New York
27. Salanti G, Amountza G, Ntzani EE et al (2005) Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 13:840-848
28. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
30. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560
31. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
32. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15-17
33. Stuck AE, Rubenstein LZ, Wieland D (1998) Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 316:469
34. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
35. Cheng XY, Cao CF, Ji B et al (2009) Association between MTHFR C677T polymorphism and osteoporotic fractures risk. Chin J Gerontol 29:2441-2443
36. Nissen N, Madsen JS, Bladbjerg EM et al (2009) No association between hip geometry and four common polymorphisms associated with fracture: the Danish osteoporosis prevention study. Calcif Tissue Int 84:276-285
37. Baines M, Kredan MB, Usher J et al (2007) The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 40:730-736
38. Kiel DP, Demissie S, Dupuis J et al (2007) Genome-wide association with bone mass and geometry in the Framingham heart study. BMC Med Genet 8(Suppl 1):S14
39. Gjesdal CG, Vollset SE, Ueland PM et al (2006) Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine study. Arch Intern Med 166:88-94
40. Riancho JA, Valero C, Zarrabeitia MT (2006) MTHFR polymorphism and bone mineral density: meta-analysis of published studies. Calcif Tissue Int 79:289-293
41. Lubec B, Fang-Kircher S, Lubec T et al (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159-162
42. Wang H, Liu C (2011) Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Osteoporos Int 23(11):2625-34
43. Peters J, Mengersen K (2008) Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses. Eval Health Prof 31:370-389
44. Simmonds MC, Higgins JP, Stewart LA et al (2005) Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2:209-217
45. Uitterlinden AG, Ralston SH, Brandi ML et al (2006) The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med 145:255-264
46. Ji GR, Yao M, Sun CY et al (2010) BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and risk of fracture in Caucasians: a meta-analysis. Bone 47:681-686
47. Richards JB, Kavvoura FK, Rivadeneira F et al (2009) Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 151:528-537
48. Mann V, Ralston SH (2003) Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 32:711-717
49. Ioannidis JP, Stavrou I, Trikalinos TA et al (2002) Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 17:2048-2060